Atlas Trials

A Study to Evaluate Time in Range in Type 2 Diabetics Using Afrezza® Plus Basal Insulin Compared to Multiple Daily Injections

Clinical trial NCT04125082 · UNKNOWN

Trial details

NCT number
NCT04125082
Sponsor
Diabetes and Glandular Disease Clinic
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes Treated With Insulin
Start date
2019-02-27
Primary completion
2020-03-15
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.